Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 April 2026 : Review article  

Role of the STAT3 Signaling Pathway in Cell Proliferation and Inflammation in Psoriasis and Approaches for Targeted Therapies: A Review

Limin Li CE 1, Lu Chen B 1, Cai Zhang BEF 2, Wenchao Yao D 1, Zhengxiao Li G 3, Faming Tian G 1,2*

DOI: 10.12659/MSM.952449

Med Sci Monit 2026; 32:e952449

Figure 4 STAT3 regulates neutrophil recruitment and NETosis in psoriasisSTAT3 regulates the recruitment and activation of neutrophils in psoriasis. It promotes skin infiltration by facilitating the release of chemokines by neutrophils. Activated neutrophils cause tissue damage through reactive oxygen species (ROS) and proteases, while STAT3-triggered neutrophil extracellular trap cell death (NETosis) amplifies the inflammatory response through the Toll-like receptor 9 (TLR9)/IL-17 axis and promotes the progression of psoriasis. IL-17 activates JAK2/STAT3 in keratinocytes to drive neutrophil chemotaxis. In the pathological microenvironment of psoriasis, IL-17 can specifically act on skin keratinocytes, inducing the activation of the intracellular JAK2/STAT3 signaling pathway. After this pathway is activated, it further upregulates the transcription and secretion of chemokines such as C-X-C motif chemokine ligand 1 (CXCL1), CXCL2, and CXCL8, recruiting neutrophils to gather at the skin inflammatory site through chemotaxis. This amplifies the local inflammatory cascade reaction, thereby promoting the occurrence and pathological progression of psoriasis. (Created with BioRender.com).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750